Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
210.20    -1.60 (-0.76%)
Bid:
210.00
Ask:
210.40
Spread: 0.40 (0.19%)
Market Cap: £4.11b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Director/PDMR Shareholding

8 Sep 2025 16:50

RNS Number : 4654Y
Convatec Group PLC
08 September 2025
 

8 September 2025

Convatec Group Plc

("Convatec" or "the Company")

 

Director/PDMR Shareholding

 

 

This announcement provides information on Persons Discharging Managerial Responsibility ("PDMR") dealings under the Convatec 2017 Save as You Earn share option scheme (the "SAYE Scheme") that took place from 2022 to present.

 

Grant of SAYE options

 

On 14 July 2022, options were granted to Jonny Mason, Interim Chief Executive Officer (then Chief Financial Officer) and PDMR over 10,346 ordinary shares of 10 pence each in the Company ("Shares") at an option price of 173.97 pence per Share under the SAYE Scheme. The options became exercisable in the ordinary course from 1 September 2025.

 

On 20 July 2023, options were granted to Karim Bitar, Chief Executive Officer and PDMR over 10,253 Shares at an option price of 175.55 pence per Share under the SAYE Scheme. The options will become exercisable in the ordinary course from 1 September 2026.

 

Exercise of SAYE options

 

On 5 September 2025, Jonny Mason, exercised options over 10,346 Shares granted on 14 July 2022 under the SAYE Scheme, at an option price of 173.97 pence per Share.

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

Details of the person discharging managerial responsibilities / person closely associated

 

Name

 

Jonny Mason

 

Reason for the notification

 

 

Position/status

 

Interim Chief Executive Officer and PDMR

 

Initial notification /Amendment

 

Initial notification

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

Name

 

Convatec Group Plc

 

LEI

 

213800LS272L4FIDOH92

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Convatec Group Plc

 

 

Identification code

GB00BD3VFW73

 

 

Nature of the transaction

Grant of options granted under the Convatec Group Plc 2017 Save As You Earn scheme

 

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£ 1.7397

10,346

 

Aggregated information

 

 

- Aggregated volume

N/A

 

 

- Price

 

 

Date of the transaction

 

14 July 2022

 

Place of the transaction

 

Outside a trading venue

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Convatec Group Plc

Identification code

GB00BD3VFW73

Nature of the transaction

Exercise of options granted under the Convatec Group Plc 2017 Save As You Earn scheme

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£ 1.7397

10,346

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

Date of the transaction

 

5 September 2025

Place of the transaction

 

Outside a trading venue

 

 

 

Details of the person discharging managerial responsibilities / person closely associated

Name

 

Karim Bitar

Reason for the notification

 

Position/status

 

Chief Executive Officer and PDMR

Initial notification /Amendment

 

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

 

Convatec Group Plc

LEI

 

213800LS272L4FIDOH92

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Convatec Group Plc

Identification code

GB00BD3VFW73

Nature of the transaction

Grant of options granted under the Convatec Group Plc 2017 Save As You Earn scheme

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£ 1.7555

10,253

Aggregated information

- Aggregated volume

N/A

- Price

Date of the transaction

 

20 July 2023

Place of the transaction

 

Outside a trading venue

 

 

 

Contacts

The person responsible for making this announcement is James Kerton, Company Secretary, Convatec Group plc: cosec@convatec.com

 

Media: MediaRelations@convatec.com

 

Investor Relations: IR@convatec.com

 

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

 

Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation

 

About Convatec

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide our products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Convatec's revenues in 2024 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVEAVITIIE
Date   Source Headline
8th Sep 20254:50 pmRNSDirector/PDMR Shareholding
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20254:45 pmRNSDirector/PDMR Shareholding
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20255:16 pmRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20259:10 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 202512:16 pmRNSHolding(s) in Company
26th Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSConvatec commences share buyback programme
18th Aug 202511:09 amRNSHolding(s) in Company
11th Aug 202510:33 amRNSHolding(s) in Company
8th Aug 20257:00 amRNSDirector/PDMR Shareholding
4th Aug 20257:00 amRNSUpdate regarding Chief Executive Officer
1st Aug 202512:18 pmRNSHolding(s) in Company
29th Jul 20257:00 amRNSInterim Results
24th Jul 20251:04 pmRNSHolding(s) in Company
15th Jul 20257:34 amRNSConvatec responds to draft CMS proposal
26th Jun 202510:30 amRNSHolding(s) in Company
2nd Jun 20253:45 pmRNSDirector/PDMR Shareholding
22nd May 20254:25 pmRNSResults of AGM
22nd May 20257:00 amRNSAGM Trading Update
29th Apr 20253:15 pmRNSHolding(s) in Company
29th Apr 20252:21 pmRNSHolding(s) in Company
28th Apr 20253:07 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSConvatec responds to LCDs postponement in US
3rd Apr 20253:21 pmRNSHolding(s) in Company
18th Mar 20255:51 pmRNSDirector/PDMR Shareholding
18th Mar 20255:45 pmRNSDirector/PDMR Shareholding
12th Mar 202512:00 pmRNSDirector/PDMR Shareholding
11th Mar 20259:00 amRNSPublication of Annual Report and Notice of AGM
26th Feb 20257:00 amRNSConvatec FY24 Results
15th Nov 202411:53 amRNSHolding(s) in Company
14th Nov 20245:52 pmRNSConvatec responds to LCDs in the United States
12th Nov 20247:00 amRNSTrading update for 10 months ended 31 October 2024
6th Nov 20249:00 amRNSHolding(s) in Company
15th Oct 20249:45 amRNSHolding(s) in Company
19th Aug 20243:17 pmRNSNotification of Major Holdings
2nd Aug 20242:39 pmRNSHoldings in Company
1st Aug 202410:12 amRNSDirector Declaration
30th Jul 20247:00 amRNSInterim Results
20th May 20243:39 pmRNSHolding(s) in Company
16th May 20245:00 pmRNSConvatec Group PLC: Results of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.